Bernardo H. L. Goulart, MD
Seattle Cancer Care Alliance
University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Lung cancer, Head and neck cancers, Thoracic oncology, Mesothelioma
One of my top responsibilities is to communicate with you compassionately and in a respectful way, knowing that you’re experiencing intense physical and personal changes that may deeply affect your life and the lives of your loved ones.”
Why did you choose to be an oncologist?
My father was an internist, which definitely influenced my choice to become a physician. Two of my main drivers professionally have been my fascination with human biology, especially the biology of cancer, and my desire to help others. My foremost motivation is to be part of the physician-patient-family relationship at a critical time in your life. It’s a challenging profession, where decisions often have huge weight. But my patients always remind me of the inherent value of life. This makes every single encounter worthy, and I look forward to it.
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
Most of my research involves studying the outcomes and pharmacoeconomics of cancer therapies. We analyze treatments in real-world settings, comparing their impact on survival and costs. I also design and conduct studies that assess the quality of cancer treatments delivered nationwide and do economic modeling of the cost-effectiveness of cancer therapies and predictive genomic tests in lung cancer — including EGFR and ALK mutation testing.
I treat patients with a range of head and neck cancers. The challenge is to provide innovative and effective therapies that are also affordable. My hopes are that molecularly targeted treatments will continue to advance and we will develop agents that are much more effective against each subtype of cancer. That means we’ll be better able to tailor treatment to you in particular while sparing you from the potential toxic effects, as well as costs, of ineffective or marginally effective therapies.
What role can patients play in getting great care?
Patients can actively participate in decisions about their treatment. The ultimate definition of good quality care is when you can make treatment decisions that reflect your core values and beliefs. My job is to provide you with the clearest and most accurate information about your disease prognosis and options so you are well informed and in the best possible position to decide what’s right for you.
Federal University of Rio de Janeiro
University of Washington
Federal University of Rio de Janeiro, Internal Medicine; Brazilian National Cancer Institute, Medical Oncology
University of Washington, Medical Oncology
Medical Oncology, 2012; General Internal Medicine, 2008, American Board of Internal Medicine
Fellowship, Massachusetts General Hospital, Outcomes Research